Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171984 | SCV000050966 | uncertain significance | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Department of Pathology and Laboratory Medicine, |
RCV000171984 | SCV001551060 | uncertain significance | not provided | no assertion criteria provided | clinical testing | The LAMA4 p.Trp271Arg variant was not identified in the literature but was identified in dbSNP (ID: rs201486893) and ClinVar (classified as uncertain significance by Biesecker Lab/Clinical Genomics Section National Institutes of Health). The variant was identified in control databases in 3 of 250760 chromosomes at a frequency of 0.00001196 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: Ashkenazi Jewish in 2 of 10062 chromosomes (freq: 0.000199) and Other in 1 of 6114 chromosomes (freq: 0.000164), but was not observed in the African, Latino, East Asian, European (Finnish), European (non-Finnish), or South Asian populations. The p.Trp271 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. |